Serum Institute of India, the leading vaccine maker from the country, will carry out phase 2 and phase 3 human trials to test the efficacy of an investigational dry powder measles vaccines which is administered through inhalation.
The anti-HIV drug fosamprenavir calcium (Lexiva) could lead to heart disease, warns the maker of the drug GlaxoSmithKline.
Caspofungin, an anti-fungal drug sold in the brand name Cancidas by Merck, can cause serious liver problems in children, warned US FDA.
TSO3 Sterizone, a low temperature sterilization device for metal and heat sensitive instruments by TSO3, has approved to expand its use for endoscopes as well, by US FDA.
Weight loss drug sibutramine, which is being sold under the brand name Meridia by Abbott, could face ban in US.